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Airborne exposure to microbial products is linked 
to asthma in complex ways (Williams et al., 
2005).  Although  heavy  exposure  early  in  life 
seems to be inversely correlated with the devel-
opment of allergy, most aeroallergens are con-
taminated with microbial products such as LPS 
that can promote allergic airway inflammation in 
experimental systems. The importance of lipids is 
further highlighted by the strikingly high fre-
quency of lipid-binding proteins among major 
allergens. For example, the common dust mite 
allergen Der p 2, which is structurally and func-
tionally homologous to MD-2, can bind a range 
of lipids, including LPS, to activate the TLR4 
pathway and render mice susceptible to allergic 
airway inflammation (Trompette et al., 2009).
In signaling through TLR4, LPS generally 
promotes Th1 responses through the induction 
of IL-12. Specific connections between micro-
bial lipids and the induction of Th2 cytokines 
that are the hallmark of allergic airway inflam-
mation  have  not  been  conclusively  estab-
lished. Gram-negative bacteria that lack the 
LPS  synthesis pathway, particularly those be-
longing to the genus Sphingomonas, are ubiqui-
tous bacterial types found in soil and aqueous 
environments and are particularly abundant in 
aerosols  (Fahlgren  et  al.,  2010).  Sphingomonas 
characteristically  uses  -glycuronosylceramides 
instead of LPS in the outer leaflet of the cell wall 
outer membrane (Kawahara et al., 2000). These 
glycolipids evade the TLR pathway and have 
attracted much attention because of their ability 
to bind CD1d and directly activate the semi- 
invariant  TCR  of  NKT  cells,  an  innate-like   
lineage of effector-type T cells that explosively 
release IL-4 and IL-13 in both mice and humans 
(Kinjo et al., 2005; Mattner et al., 2005; Sriram   
et al., 2005). Likewise, a recent study sug-
gested that house dust extracts could contain 
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Airborne exposure to microbial cell wall lipids such as lipopolysaccharide triggers  
innate immune responses that regulate susceptibility to allergic airway inflammation.  
-Glycosylceramides represent another widespread class of microbial lipids that directly 
stimulate innate-like, IL-4– and IL-13–producing, CD1d-restricted NKT cells. In this study, 
we demonstrate that NKT cells constitutively accumulate and reside in the microvascula-
ture of the mouse lung. After a single airborne exposure to lipid antigen, they promptly 
extravasate to orchestrate the formation of peribronchiolar and interstitial lymphohistio-
cytic granulomas containing numerous eosinophils. Concomitant airborne exposure to 
ovalbumin (OVA) induces the priming of OVA-specific Th2 cells and IgE antibodies by the 
same dendritic cell coexpressing CD1d and MHC class II. Although NKT cell activation 
remains confined to the lipid-exposed lung and draining lymph nodes, Th2 cells recirculate 
and seed the lung of a parabiotic partner, conferring susceptibility to OVA challenge 
months after the initial exposure, in a manner independent of NKT cells and CD1d. Thus, 
transient recruitment and activation of lung-resident intravascular NKT cells can trigger 
long-term susceptibility to allergic airway inflammation.
© 2011 Scanlon et al.  This article is distributed under the terms of an Attribution–
Noncommercial–Share Alike–No Mirror Sites license for the first six months after 
the publication date (see http://www.rupress.org/terms). After six months it is 
available under a Creative Commons License (Attribution–Noncommercial–Share 
Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/
by-nc-sa/3.0/).
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Multiple  GFP+  cells  were  observed,  mostly  within  small 
blood vessels delineated by in vivo staining with DyLight592– 
tomato lectin, with a broad distribution in peribronchiolar and 
interalveolar capillaries (Fig. 1 A). These GFP+ cells accumulated 
in the extravascular compartment after airborne exposure to 
uncharacterized lipids that directly activated NKT cells inde-
pendently of TLR signaling (Wingender et al., 2011).
Several observations suggest that NKT cell activation dur-
ing exposure to protein antigen can direct Th2 responses to 
this antigen. Mice immunized systemically (Singh et al., 1999) 
or intranasally (Kim et al., 2004) with a mixture of OVA and 
the NKT ligand -galactosylceramide (-GalCer), a synthetic 
analogue of the bacterial -glycuronosylceramides, developed 
a Th2 response to OVA, as expected from the abundant release 
of IL-4 by NKT cells and their ability to interact with the same 
DCs that prime adaptive T cells (Fujii et al., 2007). In a nasal 
immunization model, Sphingomonas lipids alone or their syn-
thetic analogue -GalCer was sufficient to induce lung eosino-
philic infiltration and airway hyperreactivity (Meyer et al., 
2006), whereas co-administration of OVA created a state of 
susceptibility to allergic airway inflammation upon later intra-
nasal exposure to OVA alone (Kim et al., 2004).
The anatomical location of NKT cells in the lung and the 
cellular mechanisms underlying their lipid-mediated activa-
tion and subsequent promotion of allergic responses have not 
been fully elucidated. In this study, we demonstrated that 
NKT cells naturally accumulated as long-term residents of the 
lung microvascular network in the resting state. Upon a single 
intratracheal exposure to their lipid ligands, intravascular NKT 
cells  rapidly  extravasated  to  peribronchiolar  and  interstitial 
spaces to orchestrate the formation of lymphohistiocytic gran-
ulomas with numerous eosinophils. Concomitant exposure to 
OVA through the same intratracheal route resulted in the 
priming of OVA-specific Th2 cells in the mediastinal LN   
and the production of IgE in a manner dependent on the co-
expression of CD1d and MHC class II by CD11c+ DCs but not 
B cells. Although NKT cell activation and their cytokine se-
cretion remained localized to the sensitized lung and its drain-
ing LNs, OVA-specific Th2 cells recirculated and could seed 
the unsensitized lung of a parabiotic partner. These Th2 cells 
conferred susceptibility to airborne OVA challenge months 
after the initial exposure and in a manner independent of 
NKT cells and CD1d. Thus, these experiments demonstrate 
that resident intravascular NKT cells are rapidly mobilized by 
exposure to airborne microbial lipids and can respond locally 
and transiently in the lung to induce long-lasting systemic   
allergic sensitization to associated protein antigens.
RESULTS
NKT cells accumulate in the lung microvasculature  
and rapidly extravasate upon airborne exposure to lipid
NKT cells are markedly overrepresented in the healthy lung 
as they represent up to 5–10% of the T cells recovered from 
this organ, compared with a frequency of 0.2% in periph-
eral circulating blood. Pulmonary blood is enriched in NKT 
cells, suggesting that, as in the liver, a fraction of NKT cells 
reside within the intravascular compartment (Thomas et al., 
2011). To identify their precise anatomical distribution, we 
used mice in which NKT cells are selectively GFP labeled 
through a knockin of egfp into the cxcr6 gene (Geissmann et al.,   
2005) and crossed them to V14-J18 TCR transgenic mice. 
Figure 1.  Intravascular location of lung V14 NKT cells.  
(A, left) Two-photon fluorescence microscopy of lung harvested from 
CXCR6GFP/+ mice and V14tg CXCR6GFP/+ mice (as indicated) injected with 
DyLight592–tomato lectin to visualize blood vessel endothelia. The inset 
demonstrates the intravascular location of a GFP+ cell (boxed area).  
(right) The frequency of intravascular (IV) and extravascular (EV) NKT cells was 
measured in three independent V14tg CXCR6GFP/+ samples counting at 
least 100 cells per lung. A GFP+ cell was scored as intravascular if it  
appeared wholly within the structure of a blood vessel within the 50-µm 
depth of examination. (B, top) Images of rehydrated 10-µm frozen sec-
tions of V14 transgenic CXCR6GFP/+ lungs at days 0, 1, and 4 after airway 
administration of 100 ng of the NKT ligand PBS57. (bottom) Characteriza-
tion of GFP+ cells by TCR- and CD1d–-GalCer tetramer staining. Num-
bers indicate mean percentage and SEM in each gate (n = 3/group).  
(C) EdU incorporation (3 h after i.v. injection) by V14tg lung lymphocytes 
stained with tetramers (n = 3/group). (D) Anti–CD45-PE label acquisition 
by CD1d–-GalCer tetramer-gated lymphocytes obtained from lungs 
harvested 2 min after i.v. injection of the antibody in V14tg mice  
exposed to airborne saline or PBS57, as indicated (n = 3/group).  
(A and D) Horizontal bars indicate the mean. *, P < 0.05. Bars, 100 µm.JEM Vol. 208, No. 10 
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NKT cell activation by agonist TCR ligands was required 
for  maximal  recruitment  and  for  cytokine  production   
and expansion.
Airborne NKT ligand triggers NKT cell activation  
and the recruitment of allergic granulomas
0.1 µg of the -GalCer analogue PBS57 was administered   
intratracheally to follow the local consequences on NKT cell 
activation in BALB/c mice over time. Within 24 h, a cellular 
infiltration was noted in the peribronchiolar and interstitial 
space, which led to the formation of well-defined granulomas 
made of monohistiocytic and giant cells, lymphocytes, and 
eosinophils by day 4 (Fig. 2 A). These allergic granulomas 
were highly reminiscent of the lesions observed in human ex-
trinsic allergic alveolitis, an acute condition induced by expo-
sure to organic dusts and commonly reported as farmer’s or 
bird fancier’s lung disease, where microbial products are be-
lieved to play a key role in allergic sensitization to associated 
protein antigens (Patel et al., 2001). To follow NKT cell   
accumulation in the extravascular compartment, mice were 
exposed to intravascular anti–CD45-PE labeling for 2 min, as 
described in the previous section. Whereas 17.8 ± 4.4% of 
lung NKT cells were protected from labeling in the absence 
of exposure to PBS57, consistent with their predominant intra-
vascular location, 38.3 ± 5.7% were no longer stained 24 h 
after exposure, confirming their extravasation into the lung 
tissue, and this proportion rose to 71.7 ± 13% at day 4 (Fig. 2 B) 
and 89.8 ± 3% at day 7 (not depicted). In parallel, the relative 
and absolute numbers of lung NKT cells were greatly increased 
at day 4 (Fig. 2 C). Granulomas peaked in size by day 
7 with several of them including typical giant cells, which 
are thought to result from the fusion of histiocytic cells, 
whereas the lung recovered a largely normal aspect by 
day 14 (Fig. S2). The nature of this granulomatous in-
filtration was also assessed by flow cytometry of cells   
extracted from the lungs, confirming the extensive   
eosinophilic and NKT cell infiltration (Fig. 2 C).
The local activation of NKT cells to release cyto-
kines was directly demonstrated by intracellular staining 
for IL-4 and IFN- ex vivo (without restimulation or 
Golgi blocking in vitro) after cell extraction from the 
lung tissue at different time points. Release of both cyto-
kines was observed at 12 h and peaked at 24 h (Fig. 3 A). 
Expression of CD25 and further up-regulation of CD69 
0.1 µg of the -GalCer analogue PBS57 (Liu et al., 2006) 
and  included  between  43  and  67%  of  CD1d–-GalCer+ 
NKT cells at different time points before and after exposure 
to lipid, attesting to their NKT lineage origin (Fig. 1 B). At   
24 h after exposure, many GFP+ cells were already found inside 
the pulmonary tissue (Fig. 1 B). This accumulation was not 
caused by local expansion because they did not incorporate   
5-ethynyl-2’deoxyuridine (EdU) after 3 h (Fig. 1 C), suggest-
ing rapid mobilization and invasion of the pulmonary tissue. 
To quantitatively follow the extravasation of NKT cells into 
the lung tissue, we briefly exposed them to anti–CD45-PE 
antibodies injected i.v. (Pereira et al., 2009). 2 min after injec-
tion, the lungs were perfused through the right ventricle with 
PBS (until they turned white) to flush out both free antibody 
and  nonadherent  red  and  white  blood  cells.  Lymphocytes 
were then extracted from the lung tissue and analyzed by flow 
cytometry. This procedure identifies lymphocytes tightly ad-
hering to the endothelial lining of the vessels because they are 
brightly labeled by the anti–CD45-PE antibody but remain in 
the lung despite the perfusion. At 24 h after lipid exposure, 
we observed a 7.4-fold increase in the absolute number of 
CD45-PE–negative NKT cells and a corresponding decrease 
in CD45-PE–positive NKT cells, without overall changes in 
total NKT cell numbers, confirming NKT cell extravasation 
and pulmonary invasion (Fig. 1 D).
In contrast, although airway exposure to a high dose of 
1 µg of the microbial TLR ligand LPS also induced the   
extravasation of NKT cells, little NKT cell expansion or cyto-
kine production could be detected (Fig. S1). Thus, direct 
Figure 2.  Extravasation of intravascular NKT cells upon 
airborne exposure to their lipid antigen. BALB/c mice re-
ceived one intratracheal instillation of 100 ng PBS57 at day 0. 
(A) H&E staining of lungs (inset shows granuloma, day 4), repre-
sentative of three mice/group. Bars, 200 µm. (B) Anti–CD45-PE 
label acquisition by B220TCR-+ gated lymphocytes obtained 
from lungs harvested 2 min after i.v. injection of the antibody  
(n = 3 mice/group). (C) Absolute numbers of eosinophils (Eo), CD4+  
T cells (CD4), NKT cells (NKT), and DCs/macrophages (DC/M) 
harvested from the lungs at the corresponding time points. All 
experiments are representative of three mice per group. Hori-
zontal bars indicate the mean.2116 Airborne lipid recruits NKT cells from vasculature | Scanlon et al.
pulmonary DCs or migration of lipid and its capture by LN 
DCs. In contrast, splenic and inguinal LN DCs failed to stimu-
late NKT cells at 24 and 48 h, in agreement with the observation 
that NKT cells were locally rather than systemically activated.
Early chemokines drive the extravasation of NKT cells
A survey of chemokine messenger RNAs induced in the 
lung 18 h after exposure to airborne NKT ligand identified 
multiple candidates involved in their extravasation (Fig. 4 A). 
Furthermore, experiments in CD1d-deficient mice demon-
strated that chemokine induction was strictly dependent on 
CD1d expression, ruling out a direct proinflammatory effect 
of the lipid on epithelial cells for example. An exception was 
CXCL2 (Fig. 4 A, #22), which was induced in response to 
saline  as  well.  Known  NKT  attractants  such  as  CCL17 
(TARC),  CXCL9  (MIG),  and  CXCL13  (BLC;  Johnston   
et al., 2003; Thomas et al., 2003; Semmling et al., 2010) were 
rapidly up-regulated in total lung proteins (Fig. 4 B). Fur-
thermore, airborne exposure to CCL17 mobilized intravas-
cular NKT cells into the lung parenchyma, as judged by the 
intravascular anti–CD45-PE assay (Fig. 4 C).
NKT-induced allergic airway  
inflammation to OVA
Next, we co-administered the model antigen 
OVA intratracheally along with the NKT lipid 
antigen. After a single intratracheal exposure to 
the mixture of 0.1 µg PBS57 and 10 µg OVA at 
day 0, mice were rested for 2 wk before a series 
of  four  intratracheal  challenges  with  10  µg 
OVA alone at days 14, 15, 17, and 18. As dem-
onstrated by the examination of cells recovered 
from bronchoalveolar lavage (BAL), a massive 
eosinophilia developed in the airways after the 
OVA challenges (Fig. 5 A). Increased airway 
reactivity to methacholine (MCh; Fig. 5 B) and 
followed the same kinetics in the lung, as expected, but also in 
the mediastinal LNs, suggesting rapid activation of NKT cells in 
the draining LNs as well (Fig. 3 A). In contrast, splenic NKT 
cells  failed  to  exhibit  cytokine  production  or  up-regulation   
of CD25 or CD69, further confirming the loco-regional nature 
of the immunological reaction to airborne NKT lipid antigen. 
Experiments of EdU incorporation by NKT cells also demon-
strated that DNA synthesis began after 24 h and peaked at 36 h 
with  >30%  EdU+  cells  in  the  lung  and  mediastinal  LNs, 
whereas the spleen showed only modest incorporation (Fig. 3 A, 
right column).
Lipid APCs
To identify the cell types involved in lipid antigen presentation 
in vivo, we purified DCs and macrophages from the lung, medi-
astinal LNs, and spleen 24 h after airway exposure to the NKT 
ligand and used them to stimulate the NKT hybridoma DN32.
D3 in vitro (Fig. 3 B). In the lung, both cell types reached near 
maximal presentation level at 24 h. In mediastinal LNs, presenta-
tion was delayed by 24 h, which is consistent with migration of 
Figure 3.  Local activation of lung NKT cells after 
airborne exposure to lipid ligand. (A, top row) Intracel-
lular IL-4 and IFN- staining of NKT cells (B220, TCR-+, 
CD1d-tetramer+) in the lung of BALB/c mice at the indi-
cated times after intratracheal (IT) instillation of  
100 ng PBS57. Quadrant numbers represent percent 
mean and SEM of three mice per group. (bottom rows) 
CD25 and CD69 expression by tetramer+ NKT cells at the 
indicated times in the lung, mediastinal LNs, and spleen. 
The right column shows the percentage of EdU+ NKT cells 
at the indicated times after intratracheal instillation of 
PBS57 or saline in the corresponding tissues. All of the 
mice in the EdU incorporation experiment also received 
10 µg OVA intratracheally. Horizontal bars indicate the 
mean. (B) Lung macrophages and DCs from lung, medi-
astinal (Med) and inguinal (Ing) LNs, and spleen (Spl) 
were FACS sorted 24 and 48 h after intratracheal instilla-
tion of 100 ng PBS57 and cultured with the PBS57- 
specific NKT cell hybridoma DN32.D3 for 1 d before 
assessing IL-2 released in supernatants. Data are repre-
sentative of two independent experiments.JEM Vol. 208, No. 10 
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exclusively provided by the interaction between lipid and 
NKT cells.
Surprisingly, despite the absence of NKT ligand during the 
OVA challenge, a massive increase of NKT cell numbers was 
observed as well (Fig. 5 A). Unlike the earlier NKT cell expan-
sion observed at the sensitization phase, this late increase was 
independent of CD1d presentation as it could not be blocked 
with anti-CD1d antibodies (Fig. S5), suggesting a cytokine 
rather  than  TCR-driven  increase  or  accumulation.  Impor-
tantly, when the challenges were delayed and administered   
6 wk rather than 3 wk after sensitization, the increase in NKT 
cells was reduced by 22-fold on average, despite equivalent 
counts of eosinophils and CD4 T cells (Fig. S6). Thus, the 
NKT cell increase observed during early OVA challenge might 
involve residual NKT cells that were previously activated by 
their lipid ligand and had not yet been cleared from the lung.
OVA-specific T cells recovered from the mediastinal LNs 
demonstrated an exclusive Th2 cytokine profile by secreting 
IL-4, IL-5, and IL-13 and no IFN- in response to OVA in 
vitro, which is consistent with a polarization of the response 
(Fig. 6 A). A similar polarization was evidenced in the anti-
body response to OVA, which consisted mainly of IgE and 
IgG1 (Fig. 6 B). This polarized cytokine response was also 
indicated by direct cytokine protein analysis in the lavage 
samples obtained after OVA challenge and contrasted with 
the mixed response observed during the sensitization phase 
(Fig. S7 A). As expected, airway inflammation was reduced 
in mice lacking IL-4 or IL-4R, but it was not modified in 
mice lacking IFN- or IL-10 (Fig. S7 B), suggesting that the 
latter cytokines did not play a major role in regulating the 
Th2 outcome of the response.
Resident versus recirculating cells in NKT cell–mediated 
allergic airway inflammation
The  aforementioned  experiments  suggested  that  the  local   
activation of NKT cells provided the adjuvant effect and the 
cytokines required for priming OVA-specific Th2 cells and 
IgE antibodies. However, NKT cell invasion and granuloma 
formation are likely to induce broader changes in the bron-
chopulmonary microenvironment as well, which may be   
important for the development of susceptibility to allergic 
airway inflammation. To further dissect the role of local   
and recirculating effector mechanisms in the pathogenesis of   
allergic airway inflammation, we generated parabiotic pairs   
using B6 mice with different CD45 alleles (Fig. 7 A). One 
parabiont was sensitized intratracheally with OVA + PBS57 
while both parabiotic partners received intratracheal OVA-
only challenges starting at day 15. Notably, both mice devel-
oped comparable accumulation of eosinophils. NKT cells 
only expanded in the sensitized mouse, further demonstrat-
ing that their prior activation by lipid antigen was a prerequi-
site for local expansion upon OVA challenge but that this 
expansion per se was not required for allergic inflammation. 
Interestingly, whereas each lung contained similar propor-
tions of CD45.1 and CD45.2 CD4 T cells, consistent with 
the recirculation properties of T cells, NKT cells exhibited a 
a typical presentation of allergic airway inflammation (Fig. 5 C) 
with peribronchiolar eosinophilic and lymphocytic infiltrates 
and mucus hypersecretion were observed at day 20. Note 
that mice sensitized with OVA alone did not develop allergic 
airway inflammation or airway hyperreactivity and that the 
Sphingomonas lipid GSL-1, an agonist ligand of mouse and 
human NKT cell, had equivalent effects to PBS57 (Fig. S3). 
Notably,  allergic  airway  inflammation  was  totally  absent   
in CD1d/ mice but was unaltered in MyD88/ mice   
(Fig. S4), directly demonstrating that the adjuvant effect was 
Figure 4.  Local chemokines induce NKT cell extravasation.  
(A) Chemokine messenger RNA expression profile of total lungs from WT or 
CD1d/ mice 18 h after airway exposure to saline or PBS57 as indicated. 
Data were normalized to control unmanipulated WT mice, with bars 
showing the mean ± SEM of two independent experiments. Shown are 
ccl1 (01), ccl2 (02), ccl3 (03), ccl4 (04), ccl5 (05), ccl6 (06), ccl7 (07), ccl8 
(08), ccl9 (09), ccl11 (10), ccl12 (11), ccl17 (12), ccl19 (13), ccl20 (14), 
ccl21 (15), ccl22 (16), ccl24 (17), ccl25 (18), ccl27a (19), ccl28 (20), cxcl1 
(21), cxcl2 (22), cxcl3 (23), pf4/cxcl4 (24), cxcl5 (25), ppbp/cxcl7 (26), cxcl9 
(27), cxcl10 (28), cxcl11 (29), cxcl12 (30), cxcl13 (31), cxcl14 (32), cxcl15 
(33), cxcl16 (34), cxcl17 (35), cx3cl1 (36), and xcl1 (37). IT, intratracheal.  
(B) Time course of protein expression of CCL17 (TARC), CXCL9 (MIG), and 
CXCL13 (BLC) in total lung lysates after intratracheal exposure to PBS57. 
Data are representative of two separate experiments with two to three 
individual mice analyzed at each time point. (C) NKT cell extravasation  
48 h after intratracheal administration of 100 ng CCL17 was measured by 
the absolute number of lung tetramer+ cells that were protected from a 
2-min intravascular anti–CD45-PE labeling. EdU incorporation after a 3-h 
pulse was <1% in all groups (not depicted). (B and C) Horizontal bars 
indicate the mean. *, P < 0.05; ***, P < 0.001.2118 Airborne lipid recruits NKT cells from vasculature | Scanlon et al.
enabled the DC-mediated priming of OVA-specific MHC 
class II–restricted CD4+ Th2 cells, the latter provided most of 
the help to OVA-specific B cells.
This scenario would predict that CD1d and MHC class II 
must be present on the same DC to induce allergic inflamma-
tion to its full extent. Indeed, in lethally irradiated CD1d/ 
hosts reconstituted with a 1:1 mixture of MHC II/ and 
CD1d/ bone marrow cells, allergic inflammation was signifi-
cantly impaired, as judged by the extent of eosinophilic infiltra-
tion (Fig. 9 A) and anti-OVA IgE antibody secretion (Fig. 9 B), 
compared with mice reconstituted with mixtures of WT and 
either MHC II/ or CD1d/ bone marrow cells.
DISCUSSION
Although CD1d-restricted V14 NKT cells have long been 
known to accumulate in the healthy lung, our experiments 
demonstrated  that  they  mainly  resided  in  the  intravascular 
space rather than in the pulmonary tissue itself and, paradoxi-
cally, that they failed to recirculate. Strikingly, these intravas-
cular  NKT  cells  were  rapidly  mobilized  after  exposure  to 
airborne lipid antigen and they responded by extravasation, the 
secretion of multiple cytokines and chemokines, and the re-
cruitment of allergic inflammatory granulomas. In the process, 
NKT cells activated DCs and enabled them to stimulate and 
differentiate CD4 Th2 cells specific for protein antigens associ-
ated with the airborne lipid. We proved the requirement for a 
three-cell NKT–DC–CD4 interaction and the pre-
dominant role of antigen-specific CD4 T cells over 
NKT cells in helping B cells produce IgE and IgG1 
antibodies to the protein antigen. These events   
ultimately created a state of allergic susceptibility 
whereby new challenge with protein antigen alone 
rapidly induced allergic airway inflammation inde-
pendently of further NKT cell involvement.
These findings have several important implica-
tions for our understanding of the biology of NKT 
cells and for their potential involvement in various 
forms of allergic pulmonary reactions ranging from 
extrinsic allergic alveolitis to asthma. The intravascu-
lar location of NKT cells was previously established 
marked bias for their original host, highlighting their resident 
properties (Fig. 7 B). Thus, NKT cells remained resident in 
their lung of origin and mainly acted as a local adjuvant sys-
tem for priming a systemic recirculating effector response, 
including  OVA-specific  Th2  cells  and  anti-OVA–specific 
IgE-producing B cells, which in turn was sufficient to transfer 
susceptibility to allergic airway inflammation.
Dual expression of CD1d and MHC class II by DCs required 
for allergic airway inflammation
Using newly developed CD1d1fl/fl mice crossed to CD11c-, 
Lyz2-, and CD19-Cre–deleter strains (Fig. S8), we investi-
gated the role of different APCs. CD1d expression by DCs 
was specifically required for the induction of allergic inflam-
mation to OVA, as shown by the abrogation of allergic in-
flammation, including eosinophilic infiltration and anti-OVA 
IgE and IgG1, in Cd11c-Cd1d/ mice and its persistence in 
Lyz2-Cd1d/ mice (Fig. 8, A and B). Cd19-Cd1d/ mice 
lacking CD1d on B cells showed intact allergic inflammation, 
indicating that CD1d presentation of lipid antigen did not 
play an important or nonredundant function in this process 
(Fig. 8 C). Surprisingly, the serum levels of anti-OVA IgG1 
and IgE antibodies in Cd19-Cd1d/ mice were comparable 
with controls, indicating that cognate interactions between 
NKT and B cells were not required for anti-OVA antibody 
production. Therefore, it is likely that although NKT cells 
Figure 5.  Airborne exposure to PBS57 + OVA renders 
mice susceptible to asthma-like response upon OVA-
only challenge. (A) Mice received 10 µg OVA along with  
100 ng PBS57 intratracheally at day 0 and were challenged 
intratracheally with 10 µg OVA at days 14, 15, 17, and 18. 
Absolute numbers of CD1d–-GalCer+ NKT cells, eosinophils, 
and CD4+ T cells in the BAL at the indicated days are shown as 
mean ± SD of three mice per group. (B) Airway hyperrespon-
siveness in response to MCh assessed at day 20 (n = 4–7/
group). Error bars represent SEM. *, P < 0.05; ***, P < 0.001. 
(C) Representative H&E micrographs of lungs from mice sen-
sitized with OVA alone or with OVA + PBS57 at day 0 and 
challenged with OVA alone before harvesting at day 20. Note 
the mucus hypersecretion and the lymphocytic and eosinophilic 
infiltration (inset) in mice sensitized with PBS57. Micrographs 
are representative of four mice per group. Bars, 100 µm.JEM Vol. 208, No. 10 
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absolutely required for the initial extravasation of lung NKT 
cells upon intratracheal exposure to their lipid ligand (unpub-
lished data). It is likely that various CD1d-expressing cell 
types can pick up and present the lipid ligand to NKT cells in 
a redundant manner. The inhaled lipid antigen might travel 
all the way to the vascular endothelium before activating 
NKT cells, or alternatively, a small proportion of NKT cells 
constitutively present within the lung tissue might be first   
activated  and  induce  the  selective  extravasation  of  their   
intravascular counterparts within 24 h through the release of 
chemokines such as CCL17 directly or via acti-
vated APCs, as recently suggested (Semmling   
et al., 2010).
It  is  interesting  in  that  regard  that  most 
other T cells retrieved from the lung of healthy 
mice were effector-type cells and also seemed 
to be inside the microvascular bed, as judged by 
in the liver, where live imaging demonstrated a crawling   
behavior on the luminal surface of endothelial cells (Geissmann 
et al., 2005; Lee et al., 2010). In the context of infection with 
a  blood-borne  pathogen  such  as  Borrelia,  liver  NKT  cells   
interacted with Kupffer cells before the formation of intra-
hepatic granulomas (Lee et al., 2010). In our study, the synthetic 
NKT cell antigen was administered intratracheally and was 
readily picked up by both macrophages and DCs. Although 
the role of lung DCs and their coexpression of CD1d and 
MHC class II molecules appeared to be dominant for the 
priming of OVA-specific allergic responses, DCs were not 
Figure 6.  Th2 polarization of OVA-specific T cells in mediastinal 
LNs. (A) Cytokine release by LN cells extracted at day 20 and cultured 
with 50 µg/ml OVA for 3 d. Circles represent individual mice. (B) Serum 
isotypes of anti-OVA antibodies at day 20 in mice untreated or exposed to 
OVA and PBS57 as indicated. Data are representative of two independent 
experiments, each with three mice per group. (A and B) Horizontal bars 
indicate the mean.
Figure 7.  Airborne priming induces recirculating effectors of  
allergic airway inflammation. (A) The CD45.1+ member of a parabiotic 
pair was sensitized with OVA + PBS57, whereas its CD45.2+ partner re-
ceived saline at day 0. Both mice were then challenged with OVA alone at 
days 14, 15, 17, and 18, and lungs were harvested at day 20 to measure 
absolute numbers of eosinophils (Eo), T cells, and NKT cells. Error bars 
represent SEM. (B) Origin of the CD4 and NKT cells recovered from the 
lungs of each parabiont at day 20. Data are representative of three para-
biotic pairs.
Figure 8.  Allergic airway inflammation in CD1d1fl/fl 
mice. (A–C) Cell counts of BAL eosinophils (Eo) and  
T cells and serum levels of anti-OVA IgE and IgG1 at day 
20 in Cd11c-Cd1d/ (A), Lyz2-Cd1d/ (B), or Cd19-
Cd1d/ (C) mice sensitized with OVA + PBS57 at day 0 
and challenged with OVA on days 14, 15, 17, and 18. 
Controls were littermates expressing the Cre transgene 
and CD1d1fl/+ or expressing CD1d1fl/fl in the absence of the  
Cre transgene. Circles represent individual mice. Horizontal 
bars indicate the mean. *, P < 0.05; ***, P < 0.001.2120 Airborne lipid recruits NKT cells from vasculature | Scanlon et al.
of chemokines that attract CD8 T cells and likely CD4 cells 
as well (Semmling et al., 2010). DCs conditioned by Th2   
cytokines may also promote the differentiation of OVA- 
specific CD4 T cells along the Th2 pathway. Indeed, the 
Th2 differentiation of OVA-specific CD4 T cells is a promi-
nent feature of this model. Notably, whereas lung NKT cells 
produced both Th1 and Th2 cytokines, they drove an OVA-
specific CD4 T cell response that was exclusively of the Th2 
phenotype. This is not the case in other immune responses 
where NKT cells were suggested to be involved, such as   
Borrelia infection in the liver (Kinjo et al., 2006) or influenza 
infection in the lung (De Santo et al., 2008), suggesting that 
additional elements, including signaling through TLRs for 
production of IL-12 and activation of NK cells may tilt the 
balance in the opposite, Th1 direction.
Another key component of the adaptive immune response 
to allergens is the production of IgE antibodies. Although it 
has been shown that NKT cells could directly help B cells 
produce  isotype  switched  antibodies  in  vivo  and  in  vitro 
(Galli et al., 2003; Lang et al., 2008; Leadbetter et al., 
2008; Mattner et al., 2008), the secretion of anti-OVA IgE 
and IgG1 antibodies in our model could occur in the absence 
of CD1d expression by B cells, likely through cognate inter-
actions with OVA-specific CD4 T cells. Similar findings 
were reported in other systems (Tonti et al., 2009), suggest-
ing that different helper pathways are available. Thus, B cell 
help coming from either CD4 helper T cells or NKT cells 
may be redundant, or alternatively, one pathway may pre-
dominate depending on the form and strength of antigens.
The model of allergic airway inflammation examined in 
this study differs fundamentally from the traditional OVA-
alum model in which sensitization is induced by intraperito-
neal injection, and in the absence of defined NKT cell antigen, 
a  direct  involvement  of  NKT  cells  remains  controversial   
(Akbari et al., 2003; Lisbonne et al., 2003; Das et al., 2006). Our 
model is potentially relevant to several forms of human dis-
eases caused by pulmonary hypersensitivity. First, some of the 
most abundant gram-negative bacteria on earth do not express 
LPS in their cell wall, and the best characterized alternatives to 
LPS are the -glycuronosylceramides used by members of the 
widespread Sphingomonas genus, which function as NKT cell 
agonists (Long et al., 2007; Kinjo et al., 2008). Because Sphin-
gomonas is ubiquitously found in soil and aqueous environ-
ments  and  is  particularly  abundant  in  airborne  particles 
(Fahlgren et al., 2010), pulmonary exposure to NKT agonist 
ligands is likely to occur repeatedly in some environments. 
Notably, NKT agonists can exert biological effects at very low 
doses. Although in this model we used a dose of 100 ng to 
obtain consistent results across the entire lung, we have also 
observed reliable allergic inflammation after a single exposure 
to 10 ng of lipid (unpublished data). Therefore, it seems likely 
that repeated exposure to natural aerosols containing even 
very low amounts of microbial lipids might have significant 
pathological implications in some individuals. In addition, phos-
pholipids from pollens were reported to bind CD1d and acti-
vate human V24 NKT cells (Agea et al., 2005). Finally, it is 
their intravascular staining with anti–CD45-PE. As these cells 
were obtained after perfusion of the lung, they likely repre-
sented  transiently  or  permanently  adhering  populations. 
Some of these effector type T cells also extravasated within 
the first few days after airborne administration of the NKT 
ligand but in much smaller relative proportion than NKT 
cells. Interestingly, a recent study has documented the pres-
ence of very large populations of effector-type T cells in the 
noninflamed lung of humans (Purwar et al., 2011). These 
findings suggest that both adaptive and innate-like effector   
T cells, possibly enriched for specificity against pathogens or 
allergens commonly encountered in these tissues, such as in-
fluenza  virus  in  the  lung,  may  reside  within  intravascular 
compartments, ready to invade the tissue to provide rapid 
host defense.
The requirement for coexpression of CD1d and MHC 
class II on DCs suggests that a three-cell interaction involving 
NKT cells, DCs, and OVA-specific T cells must occur to 
enable the full-blown allergic response after OVA challenge. 
Such a requirement may play out at multiple levels (Moody, 
2006; Bendelac et al., 2007; Fujii et al., 2007). Resting or 
immature DCs effectively present lipid to NKT cells, inde-
pendently of TLR signaling. In return, NKT cells activate 
DCs through CD40L–CD40 interactions and enhance their 
capacity to activate OVA peptide–specific CD4 T cells (Fujii 
et al., 2004). DCs activated by NKT cells secrete a distinct set 
Figure 9.  Mixed bone marrow chimeras demonstrate a require-
ment for joint expression of CD1d and MHC class II by APCs.  
(A and B) BAL eosinophil counts (A) and anti-OVA IgE serum levels (B) in 
individual CD1d/ mice reconstituted with 1:1 mixtures of bone mar-
rows as indicated. Data are a compilation of three separate experiments 
in which reconstitution by CD45.1+ and CD45.2+ bone marrow–derived 
cells was 38.8 ± 4.7% and 61.2 ± 4.7%, respectively. Horizontal bars indi-
cate the mean. **, P < 0.01; ***, P < 0.001.JEM Vol. 208, No. 10 
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MATERIALS AND METHODS
Mice. WT C57BL/6J, CXCR6-EGFP knockin (B6.129P2-Cxcr6tm1Litt/J), 
CD1d/  (B6.129S6-Cd1d1/Cd1d2tm1Spb/J),  and  CD45.1  congenic   
mice (B6.SJL-Ptprca Pep3b/BoyJ), all on the C57BL/6 background, were   
purchased from The Jackson Laboratory. CD45.1 congenic I-Ab/ mice 
(B6.SJL(129)-Ptprca/BoyAiTac H2-Ab1tm1Gru N7+N6) on the C57BL/6 
background  were  purchased  from  Taconic.  WT  BALB/cJ,  IL-4/ 
(BALB/c-Il4tm2Nnt/J), IL-4R/ (BALB/c-Il4ratm1Sz/J), IL-10/ 
(C.129P2(B6)-Il10tm1Cgn/J),  IFN-/  (C.129S7(B6)-Ifngtm1Ts/J), 
and CD1d/ (C.129S2-Cd1tm1Gru/J), all on the BALB/c background, 
were purchased from The Jackson Laboratory. BALB/c.MyD88/ mice 
were  obtained  from  A.  Chong  (University  of  Chicago,  Chicago,  IL). 
J18/ mice on the B6 and BALB/c backgrounds were obtained from   
M. Taniguchi (RIKEN Research Center, Yokohama, Japan; Cui et al., 1997). 
V14-J18 transgenic mice in the C57BL/6 background were generated as 
previously described (Griewank et al., 2007). Age- and sex-matched animals 
were used between 5 and 12 wk of age. For experiments involving knockout 
mice, controls were heterozygous littermates.
The C57BL/6.CD1d1fl/fl strain carries loxP sites flanking exons 2 and   
6 of the C57BL/6 Cd1d1 allele. These mice were crossed with CD19-cre 
(B6.129P2I-Cd19tm1(cre)Cgn/J), CD11c-cre (C57BL/6J-Tg(Itgax-cre,-EGFP) 
4097Ach/J), or LysM-cre mice (B6.129P2-Lyz2tm1(cre)Ifo/J), all pur-
chased from The Jackson Laboratory. All mice were raised in a specific 
pathogen-free environment at the University of Chicago, and experiments 
were performed in accordance with the guidelines of the Institutional   
Animal Care and Use Committee.
Intratracheal administration of lipids and proteins. Mice were anesthe-
tized with 1.5 mg ketamine and 150 mg xylazine and received 10 mg OVA 
(grade V; Sigma-Aldrich), 100 ng of the synthetic NKT lipid agonist PBS57 
(Liu et al., 2006), or a mixture of both in a final volume of 100 ml PBS, admin-
istered in two intratracheal aspirations of 50 ml each separated by 15 min on day 0. 
For LPS experiments, mice received 1 µg ultrapure LPS (Escherichia coli O111:
B4; InvivoGen) in a final volume of 100 µl PBS, administered in two intratra-
cheal aspirations of 50 µl each separated by 15 min. For chemokine administra-
tion experiments, mice received 100 ng of carrier-free recombinant murine 
CCL17 (<1 endotoxin unit/µg; R&D Systems) in a final volume of 100 µl PBS, 
administered in two intratracheal aspirations of 50 µl each separated by 15 min.
Allergic airway inflammation model. To induce allergic inflammation to 
OVA, mice were anesthetized and sensitized by intratracheal administration 
of 10 mg OVA and 100 ng of the synthetic NKT lipid agonist PBS57 as   
described in the previous section and then challenged on days 14, 15, 17, and 
18 with OVA alone intratracheally. Mice were killed on day 20 for analysis.
Airway hyperresponsiveness experiments. Mice were anesthetized with 
2.5 mg ketamine and 250 µg xylazine. After tracheostomy, the trachea was 
cannulated with a blunt 18-gauge metal needle, and the mouse was venti-
lated  with  a  computer-controlled  small-animal  ventilator  (flexiVent;   
SCIREQ) using tidal volume 1 of 10 ml/kg and a respiratory frequency of 
150 breaths/min. Positive end-expiratory pressure of 2 cm H2O was applied 
throughout. An external jugular vein was isolated for i.v. infusion of MCh. 
To obtain a dose–response curve, a bolus of MCh was injected starting at a 
dose of 1.25 µg (solution at 125 µg/ml, with volume bolus of 10, 20, 40, 80, 
and 160 µl). After each dose was administrated, the expiratory path was ob-
structed for 15 s to produce a deep inflation after which exhalation was im-
mediately allowed. Ventilation was continued for 2 min between consecutive 
MCh doses. Airway responsiveness was quantified as Newtonian resistance 
at the highest dose of MCh given.
Parabiotic mice. Mice were anesthetized with 100 mg/kg ketamine and 
10 mg/kg xylazine. A linear incision was made from the scapulae to the 
lower abdomen on opposing sides of each member of the pair. Animals were 
placed side by side, and skin edges were sewn together. Mice were rested a 
minimum of 10 d before experiments.
striking that a large fraction of allergens, including aeroaller-
gens, are lipid-binding or lipid transfer proteins (Thomas et al., 
2005) and that some of them such as Der p 2 can signal 
through the TLR pathway and promote allergic airway in-
flammation (Trompette et al., 2009). Repeated exposure to 
trace amounts of these airborne lipids and lipid transfer pro-
teins, alone or in combination, might represent a key environ-
mental component of asthma susceptibility in humans. In that 
respect, a recent study of house dust extracts suggested the 
presence of lipid ligands that could directly activate NKT cells 
(Wingender et al., 2011).
It is noteworthy that the histopathological pattern associ-
ated with NKT ligand inhalation, with its diffuse interstitial 
granulomas made of monohistiocytes, lymphocytes, and eo-
sinophils, resembled extrinsic allergic alveolitis or hypersensi-
tivity pneumonitis, a human condition observed in subjects 
exposed to organic dusts loaded with microbial products (Patel 
et al., 2001). So-called farmer’s or bird fancier’s lung are occu-
pational diseases with symptoms beginning a few hours after 
exposure to moldy hay in a barn or to bird droppings, for ex-
ample.  These  acute  diseases  can  sometimes  evolve  toward 
chronic lung fibrosis, perhaps induced by IL-13. The patients 
may also develop allergy to associated protein antigens, such as 
avian proteins, similar to the sensitization to OVA in our ex-
perimental system, suggesting that NKT cells could be in-
volved in a spectrum of pulmonary hypersensitivity reactions.
Interestingly, whereas NKT cells recovered from the lung 
or the BAL were markedly increased after exposure to airborne 
lipid at the sensitization phase of our experimental model, they 
did not increase upon a delayed (>6 wk) challenge to OVA 
alone, despite intense allergic airway inflammation. This may 
be relevant to the controversial reports regarding the presence 
of NKT cells in the BAL of humans with asthma (Akbari et al., 
2006;  Thomas  et  al.,  2010).  Indeed,  a  striking  conclusion 
emerging from our study is that pulmonary NKT cells may act 
locally and transiently to induce long-term allergy to protein 
antigens. When reexposure to protein allergen occurred late 
after the sensitizing event, there was no obvious marker of the 
involvement of NKT cells.
In summary, this study establishes the unique topography 
and biology of lung NKT cells and their ability to induce a 
spectrum  of  pulmonary  hypersensitivity  reactions  ranging 
from extrinsic allergic alveolitis to asthma. These results and a 
recent study suggesting the presence of NKT ligands in house 
dust extracts (Wingender et al., 2011) emphasize the need to 
consider NKT cells and their airborne ligands as potential 
contributors, along with other known factors, to allergic pul-
monary diseases in humans. In addition, this study helped 
characterize a robust and simple experimental model of aller-
gic airway inflammation exclusively based on airborne expo-
sure to allergens, which stands in contrast with the broadly 
used experimental systems based on intraperitoneal immuni-
zation with alum-adsorbed antigen. Models involving unique 
components of the local innate immune system of the lung 
(Barrett and Austen, 2009) should yield novel insights into the 
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(Agilent  Technologies).  Primers  used  were  IL-4–F  (5-TCATCGGCATTTT-
GAACGAG-3),  IL-4–R  (5-CGTTTGGCACATCCATCTCC-3), 
IL-13–F (5-GAGCAACATCACACAAGACCAGA-3), IL-13–R (5-GGC-
CAGGTCCACACTCCATA-3),  IFN-–F  (5-AACGCTACACACTG-
CATCTTGG-3), and IFN-–R (5-GCCGTGGCAGTAACAGCC-3).
Serum antibodies. Serum was prepared from blood samples using yellow 
cap serum separator tubes (BD). Total and specific antibody levels were   
determined by means of sandwich ELISA as previously described (Ganeshan 
et al., 2009). For anti-OVA IgE ELISAs, a reference monoclonal anti-OVA 
IgE was provided by P. Bryce (Northwestern University, Chicago, IL).
Cell culture. Culture medium consisted of RPMI 1640 (Cellgro) supple-
mented with 10% FCS (Bio-West), 50 µM -mercaptoethanol, 100 U/ml 
penicillin–100 µg/ml streptomycin (Sigma-Aldrich), and 25 µg/ml genta-
micin (Invitrogen). Cells were cultured at 37°C, 5% CO2. For OVA stimula-
tion of mediastinal LN cells, isolated mediastinal LNs were adjusted to a 
final concentration of 2 × 105 cells/well in a round-bottom 96-well plate 
and were cultured with or without 50 µg/ml OVA for 3 d in 200 µl of   
culture medium.
Flow cytometry. CD1d-PBS57 tetramers were prepared as previously de-
scribed (Benlagha et al., 2000). Fluorochrome-labeled monoclonal anti-
bodies (clone indicated in parentheses) against mouse B220 (RA3-6B2), CCR3   
(83101), CD1d (1B1), CD3 (17A2), CD4 (GK1.5 or L3T4), CD8 (53–
6.7), CD11b (M170), CD11c (HL3), CD19 (1D3), CD45.1 (A20), CD45.2 
(104), F4/80 (BM8), GR-1 (RB6-8C5), IA/IE (2G9), IL-4 (11B11), IFN- 
(XMG1.2), NK1.1 (PK136), and TCR- (H57-597) were purchased from 
eBioscience, BD, R&D Systems, or BioLegend. For intracellular flow cytom-
etry, cells were first stained for extracellular antigens and then fixed, perme-
abilized, and stained with fluorescently labeled anticytokine antibodies for   
30 min using the Cytofix/Cytoperm kit (BD).
EdU incorporation experiments. 1 mg EdU (Invitrogen) was injected i.v. 3 h   
before analysis. Cells were fixed and stained with a Pacific blue–labeled Click-iT   
anti-EdU kit (Invitrogen) according to the manufacturer’s instructions.
In vivo tracking of lipid APCs. Mice were given 100 ng PBS57 or saline 
via intratracheal aspiration at day 0. At 24 and 48 h, lungs were prepared as 
described in Preparation of lung tissue for cellular analysis. Spleens were in-
jected with 1 ml of 1 mg/ml collagenase P (Thermo Fischer Scientific) in 
HBSS, minced, and mixed with an additional 1 ml of 1 mg/ml collagenase 
P and incubated in 5% CO2 at 37°C for 20 min before isolation of APCs. 
Alveolar macrophages were sorted as green autofluorescent+CD11c+CD19
CD3 cells, whereas DCs were sorted as green autofluorescentCD11c+CD
19CD3 cells. The NKT hybridoma DN32.D3 was added at 5 × 104 cells/
well and incubated overnight with 5 × 104 splenic DCs, inguinal LN DCs, 
mediastinal DCs, lung DCs, or alveolar macrophages. The 24-h supernatants 
were assayed for IL-2 using an ELISA kit (R&D Systems).
Generation of mixed bone marrow chimeras. 6–8-wk-old B6.CD1d/ 
mice were subjected to 9.5 Gy irradiation with a gamma cell 40 irradiator 
equipped with a cesium source. 3–6 h later, irradiated mice were i.v. injected 
with a total of 2 × 106 bone marrow cells obtained from femurs. Mice were 
rested for at least 6 wk after irradiation before experiments.
In vivo treatment with anti-CD1d antibodies. Mice were injected with 
100 µg anti-CD1d antibody 20H2 (rat IgG1; Roark et al., 1998) or isotype 
control at days 1.5 and 1.5 (sensitization) or days 12.5 and 15.5 (challenge).
Data analysis. Results are expressed as the means ± SEMs. Statistical sig-
nificance was determined using the unpaired Student’s t test, except for the 
MCh response (two-way analysis of variance) and the NKT cell extravasa-
tion assay in response to CCL17 (Fisher’s exact test, two tailed), using Prism 
Software 4.0 c for Macintosh (GraphPad Software).
Preparation of lung tissue for cellular analysis. Cell suspensions of lung 
tissue were prepared by first perfusing lungs with ice-cold PBS in situ. Lung 
tissue was then diced and incubated in 5 ml RPMI 60 medium with 0.1% 
DNase I (fraction IX; Sigma-Aldrich) and 1.6 mg/ml collagenase P (Roche) 
in a 37°C shaking incubator for 30 min. Cell suspensions were then strained 
through a nylon mesh cell strainer (Thermo Fischer Scientific) and washed 
with 25 ml RPMI with 5% FCS. Cells were centrifuged once at 300 g for   
5 min with no brake. Cell pellets were resuspended in 5 ml of 44% Percoll 
(Sigma-Aldrich), underlaid with 3 ml of 66% Percoll, and centrifuged for   
20 minutes at 30,000 g with no brake. Leukocytes were recovered from the 
interface of the gradient layers and washed.
Preparation of tissues for microscopic analysis. For histology, lungs 
were perfused through a needle inserted in the right ventricle with cold PBS 
in situ before removal and fixation in 4% paraformaldehyde (histological 
grade; Thermo Fischer Scientific) under a vacuum overnight and then trans-
ferred to PBS for 24 h at 4°C. Lobes were sectioned sagittally, embedded in 
paraffin, and cut into 5-µm sections before staining with hematoxylin and 
eosin (H&E). For experiments of CXCR6GFP/+ mice, lungs were prepared as 
in the same way, but fixation was in 2% buffered paraformaldehyde made 
from  16%  EM  grade  paraformaldehyde  (Electron  Microscopy  Sciences). 
Lungs of CXCR6GFP/+ mice were examined as whole tissues in some experi-
ments using two-photon imaging. In other experiments, they were embed-
ded in OCT (Tissue-Tek), cut onto 5–15-µm sections, allowed to air dry, 
and rehydrated just before analysis.
Imaging. To visualize blood vessels, anesthetized mice were i.v. injected 
with 100 µg of Dylight594-labeled Lycopersicon esculentum (tomato) lectin 
(Vector Laboratories) in a 200-µl volume. After 5 min, mice were killed, and 
tissues were prepared as described in the previous section. Whole lungs were 
placed on a dish with PBS and visualized using an SP5 II microscope (Leica). 
Histology micrographs were taken with the FSX-100 microscope camera 
system  (Olympus).  Data  were  analyzed  using  ImageJ  software  (National   
Institutes of Health).
Cytokine analysis. BAL fluid and supernatants from cultured cells were   
assayed for cytokines using Mouse Grp I Cytokine 23-Plex Panel (Bio-Rad 
Laboratories) and the BioPlex analyzer (Bio-Rad Laboratories) or using the 
Cytometric Bead Array mouse Th1/Th2/Th17 cytokine kit (BD) and the 
LSR II flow cytometer (BD) according to the manufacturer’s instructions. 
Data were analyzed using corresponding commercial software.
Chemokine analysis. Perfused lungs were snap-frozen in liquid nitrogen 
and homogenized in 1 ml PBS with 1× Protease Inhibitor Cocktail and   
1 µM EDTA (Thermo Fisher Scientific). Total protein was quantitated   
using the Protein Assay (Bio-Rad Laboratories) according to the manufac-
turer’s instructions. Chemokines were quantitated by incubating protein 
homogenates on the Quantibody Mouse Chemokine Array 1 (RayBio-
tech) according to the manufacturer’s instructions. Data extraction was 
performed using a GenePix 4000B Microarray scanner and GenePix Pro 
software (Molecular Devices). CCL17 was also independently measured 
using the mouse CCL17 DuoSet ELISA kit (R&D Systems) according to 
the manufacturer’s instructions. Total RNA was isolated from snap-frozen 
perfused lungs as described above, and expression levels were measured   
using mouse genome 430 2.0 array analyzed with GeneChip analysis soft-
ware (Affymetrix).
Quantitative real-time PCR. Total RNA was isolated from the perfused 
lungs that were then snap-frozen in liquid nitrogen and homogenized in a   
1-ml volume of TRIZOL (Invitrogen). RNA was isolated using the RNeasy 
mini kit (QIAGEN) according to the manufacturer’s instructions and then 
reverse  transcribed  with  random  primers  using  the  AffinityScript  qPCR 
cDNA Synthesis kit (Agilent Technologies). Quantitative real-time PCR 
was performed on an Mx3005p using Brilliant SYBR green qPCR Master   
Mix (Agilent Technologies), and data were analyzed using qPCR software   JEM Vol. 208, No. 10 
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